We´ve moved

As the first company, alongside the Life Science Factory team, we moved to the new Sartorius quarter on Weender Landstrasse on January 1st, 2022. We are enthusiastic about the [...]

Curexsys acquires new IP

Curexsys acquires a family of patents (EP2195430 & EP 3199633, US8729038 & US9951329, CA2699638, JP2010538625) enabling both targeted delivery of therapeutics and transfer of multiple therapeutic modalities including small [...]

Jörg Neermann joins Curexsys as CEO

Göttingen, Germany, May 1, 2021 – Curexsys GmbH, a new, pre-clinical stage therapeutic company developing iMSC derived exosomes for age-related diseases and anti-aging therapies, announced the appointment of Dr [...]

Nach oben